Mitt Romney detailed some of his previously vague healthcare policy to supporters in Florida yesterday, saying he wants to repeal Obamacare and apply free-enterprise principles to the healthcare system, allowing competition to drive down prices and encourage quality care. Diverting federal Medicaid funding to states, allowing the purchase of insurance across state lines, and covering people with pre-existing conditions are also part of his plan. But he didn’t address some of his Massachusetts strategies, like requiring insurance policies and offering subsidies to those who can’t afford it.
Rumors continue to swirl that GSK is in advanced discussions to buy BioMarin (NASDAQ:BRMN), a developer of enzyme replacement therapies for chronic genetic disorders.
What goes on behind closed doors as the Relative Value Update Committee decided healthcare pricing? American Public Media’s Marketplace tries to put together some of the pieces.
Could the announcement that some insurers will uphold certain provisions of the healthcare reform law regardless of how the Supreme Court rules backfire? Blue Shield of California has resisted following United Health, Aetna and Humana because it may make it easier for the court to rule against the law, since it demonstrates that regulations aren’t necessarily needed to make a change. But there are many other parts of the law these insurers haven’t made promises about…
By Deanna Pogorelc MedCity News
Deanna Pogorelc is a Cleveland-based reporter who writes obsessively about life science startups across the country, looking to technology transfer offices, startup incubators and investment funds to see what’s next in healthcare. She has a bachelor’s degree in journalism from Ball State University and previously covered business and education for a northeast Indiana newspaper.More posts by Author
- Get Livefyre
- FAQ
